BFSG LLC’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.13K Buy
+6
New +$3.29K ﹤0.01% 709
2024
Q1
– Sell
-3
Closed -$1.67K – 682
2023
Q4
$1.67K Buy
+3
New +$1.41K ﹤0.01% 551
2021
Q2
– Sell
-1,626
Closed -$796K – 163
2021
Q1
$796K Buy
+1,626
New +$815K 0.13% 149
2019
Q4
– Sell
-2,201
Closed -$599K – 205
2019
Q3
$599K Sell
2,201
-32
-1% -$8.9K 0.13% 123
2019
Q2
$615K Sell
2,233
-79
-3% -$19.5K 0.24% 76
2019
Q1
$517K Buy
+2,312
New +$477K 0.19% 95
2018
Q4
– Sell
-1,918
Closed -$479K – 109
2018
Q3
$479K Buy
+1,918
New +$466K 0.2% 99

Other funds holding IDXX

BFSG LLC's IDXX Position: Q3 2026 in Review

BFSG LLC opened a new position in Idexx Laboratories (IDXX) in Q3 2026: 6 shares worth $3.13K. The stake represents ﹤0.01% of the portfolio and ranks #709 among its holdings. This is a return to the name: BFSG LLC previously reported a position in IDXX as recently as Q4 2023.

BFSG LLC first reported a position in IDXX in Q3 2018 and has held it in 7 quarters since. The position peaked at $796K in Q1 2021. 743 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • BFSG LLC held 6 shares of Idexx Laboratories worth $3.13K as of Q3 2026.
  • Idexx Laboratories was a new BFSG LLC position in Q3 2026.
  • Idexx Laboratories made up ﹤0.01% of BFSG LLC's portfolio in Q3 2026, its #709 holding.
  • BFSG LLC first reported a position in Idexx Laboratories in Q3 2018 and has held it in 7 quarters since.
  • BFSG LLC's Idexx Laboratories position peaked at $796K in Q1 2021.
  • 743 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on BFSG LLC's 13F filing for Q3 2026, filed 30 Oct 2026.